Glow LifeTech (TSE:GLOW) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Glow Lifetech Corp. plans to issue 10 million shares to finalize its acquisition of Swiss Pharma, strengthening their strategic partnership in the cannabis and natural health sectors. Additionally, Glow intends to settle $510,470.44 in outstanding debt by issuing over 8 million shares, aiming to preserve cash for working capital.
For further insights into TSE:GLOW stock, check out TipRanks’ Stock Analysis page.
